Dermata Therapeutics (DRMA) Institutional Ownership $1.18 -0.03 (-2.08%) As of 03:34 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Dermata Therapeutics (NASDAQ:DRMA)CurrentInstitutional OwnershipPercentage8.67%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$39.44KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.73M Get DRMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Dermata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data DRMA Institutional Buying and Selling by Quarter Dermata Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/16/2026 Clear Street Group Inc.17,000$39K0.0%N/A0.599% 11/17/2025 Armistice Capital LLC81,654$410K0.0%-74.7%11.973% 8/14/2025 Armistice Capital LLC322,179$188K0.0%-21.6%50.498% 5/15/2025Armistice Capital LLC411,000$444K0.0%+1,411.0%6.813% 8/15/2024Armistice Capital LLC28,000$67K0.0%N/A4.982% 2/13/2024Armistice Capital LLC218,000$133K0.0%N/A6.158% 11/13/2023Acadian Asset Management LLC75,538$79K0.0%+34.2%2.368% 8/7/2023Acadian Asset Management LLC56,285$92K0.0%N/A2.405% 7/27/2023Virtu Financial LLC32,105$53K0.0%N/A1.372% 11/7/2022Virtu Financial LLC70,808$37K0.0%N/A0.701% DRMA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRMA shares? During the previous two years, the following institutional investors and hedge funds held shares of Dermata Therapeutics shares: Armistice Capital LLC ($410K), Clear Street Group Inc. ($39K).Learn more on Dermata Therapeutics' institutional investors. What percentage of Dermata Therapeutics' stock is owned by institutional investors? 8.67% of Dermata Therapeutics' stock is owned by institutional investors. Learn more on DRMA's institutional investor holdings. Which institutional investors have been buying Dermata Therapeutics' stock? The following institutional investors have purchased Dermata Therapeutics' stock in the last 24 months: Armistice Capital LLC ($411.80K), and Clear Street Group Inc. ($17K). How much institutional buying is happening at Dermata Therapeutics? Institutional investors have bought a total of 17,000 shares in the last 24 months. This purchase volume represents approximately $39.44K in transactions. Which of Dermata Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Dermata Therapeutics stock in the last 24 months: Armistice Capital LLC ($329.35K). How much institutional selling is happening at Dermata Therapeutics? Institutional investors have sold a total of 329,346 shares in the last 24 months. This volume of shares sold represents approximately $1.73M in transactions. Related Companies KTTA Institutional Ownership CPHI Institutional Ownership QNTM Institutional Ownership CVKD Institutional Ownership QNCX Institutional Ownership LGVN Institutional Ownership COCP Institutional Ownership ANEB Institutional Ownership LPCN Institutional Ownership LEXX Institutional Ownership This page (NASDAQ:DRMA) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
